Constitutively active ErbB4 and ErbB2 mutants exhibit distinct biological activities.
about
Phosphorylation of ErbB4 on tyrosine 1056 is critical for ErbB4 coupling to inhibition of colony formation by human mammary cell linesEGFR ligands exhibit functional differences in models of paracrine and autocrine signalingThe E3 ubiquitin ligase WWP1 selectively targets HER4 and its proteolytically derived signaling isoforms for degradationHER4 D-box sequences regulate mitotic progression and degradation of the nuclear HER4 cleavage product s80HER4.Ligand stimulation of ErbB4 and a constitutively-active ErbB4 mutant result in different biological responses in human pancreatic tumor cell lines.ErbB2 Is Necessary for ErbB4 Ligands to Stimulate Oncogenic Activities in Models of Human Breast Cancer.A systematic study of modulation of ADAM-mediated ectodomain shedding by site-specific O-glycosylation.Mutational activation of ErbB family receptor tyrosine kinases: insights into mechanisms of signal transduction and tumorigenesis.The Q43L mutant of neuregulin 2β is a pan-ErbB receptor antagonist.Multiple Functional Motifs Are Required for the Tumor Suppressor Activity of a Constitutively-Active ErbB4 Mutant.Phosphorylation of ErbB4 on Tyr1056 is critical for inhibition of colony formation by prostate tumor cell lines.The antibody sc-33040-R fails to specifically recognize phosphorylation of ErbB4 on tyrosine1056Proteolytic cleavage and phosphorylation of a tumor-associated ErbB4 isoform promote ligand-independent survival and cancer cell growthZinc finger transcription factors designed for bispecific coregulation of ErbB2 and ErbB3 receptors: insights into ErbB receptor biology.
P2860
Q24318725-EE268D89-9740-4BEB-B238-7CBEE2F6C49CQ26864769-4D112B6F-E2B6-4251-AB08-C9EACC65C972Q28511737-200BC63C-26F2-4154-8BF6-440DE50F7FF6Q34048293-3ECBF8FC-834D-4A59-BC51-C41A3A88DDEBQ34496697-D2D25C9A-E8FA-4837-A302-8179D649987BQ35755192-DDF524A9-38A6-4367-AC41-7B7B179901A5Q36332111-5E23EF9E-DE56-4A64-8C7A-D07A7D691C34Q36824808-98B7B516-0D88-4E9A-8559-E19AD25653FAQ37650953-4B50908F-04C3-4C4C-BAF2-A7CB9138F713Q37727542-6A2A3C6A-D469-4087-B76F-D7CF7AD004E3Q38787643-06114148-599A-404A-8A0F-DEF13D692AF1Q39406282-09CD49FE-0470-42FE-BE5E-D20B2E5DC6DDQ40357721-71A9857E-8BCC-451E-9635-700280966338Q40366552-E8F8AC14-8BD0-4E78-A138-5583DB312F0D
P2860
Constitutively active ErbB4 and ErbB2 mutants exhibit distinct biological activities.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Constitutively active ErbB4 and ErbB2 mutants exhibit distinct biological activities.
@en
type
label
Constitutively active ErbB4 and ErbB2 mutants exhibit distinct biological activities.
@en
prefLabel
Constitutively active ErbB4 and ErbB2 mutants exhibit distinct biological activities.
@en
P2093
P1476
Constitutively active ErbB4 and ErbB2 mutants exhibit distinct biological activities.
@en
P2093
David J Riese
Desi J Penington
Ianthe Bryant
P304
P577
2002-06-01T00:00:00Z